Soligenix to present at upcoming investor conferences

Princeton, n.j., jan. 6, 2022 /prnewswire/ -- soligenix, inc. (nasdaq: sngx) (soligenix or the company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the company will deliver a corporate presentation at the upcoming virtual investor conferences below.
SNGX Ratings Summary
SNGX Quant Ranking